• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种由高脂高胆固醇饮食诱导的新型仓鼠非酒精性脂肪性肝炎模型。

A novel hamster nonalcoholic steatohepatitis model induced by a high-fat and high-cholesterol diet.

作者信息

Miyaoka Yuta, Jin Denan, Tashiro Keitaro, Masubuchi Shinsuke, Ozeki Maiko, Hirokawa Fumitoshi, Hayashi Michihiro, Takai Shinji, Uchiyama Kazuhisa

机构信息

Department of General and Gastroenterological Surgery, Osaka Medical College, 2-7 Daigaku-machi, Takatsuki-shi, Osaka 569-8686, Japan.

Department of Innovative Medicine, Graduate School of Medicine, Osaka Medical College, 2-7 Daigaku-machi, Takatsuki-shi, Osaka 569-8686, Japan.

出版信息

Exp Anim. 2018 May 10;67(2):239-247. doi: 10.1538/expanim.17-0126. Epub 2018 Jan 1.

DOI:10.1538/expanim.17-0126
PMID:29311502
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5955755/
Abstract

Nonalcoholic steatohepatitis (NASH), in which there is steatosis and fibrosis in the liver, is linked to metabolic syndrome and progresses to hepatic cirrhosis. In this study, a novel hamster NASH model derived from metabolic syndrome was made using hamsters. Hamsters were fed a normal or a high-fat and high-cholesterol (HFC) diet for 12 weeks. Body weight and the ratio of liver weight to body weight were significantly greater in HFC diet-fed hamsters than in normal diet-fed hamsters. Triglyceride, low-density lipoprotein cholesterol, and glucose levels in blood were significantly increased in HFC diet-fed hamsters, and blood pressure also tended to be high, suggesting that the HFC diet-fed hamsters developed metabolic syndrome. Hepatic steatosis and fibrosis were observed in liver sections of HFC diet-fed hamsters, as in patients with NASH, but they were not seen in normal diet-fed hamsters. Chymase generates angiotensin II and transforming growth factor (TGF)-β, both of which are related to hepatic steatosis and fibrosis, and a significant augmentation of chymase activity was observed in livers from HFC diet-fed hamsters. Both angiotensin II and TGF-β were also significantly increased in livers of HFC diet-fed hamsters. Thus, HFC diet-fed hamsters might develop metabolic syndrome-derived NASH that clinically resembles that in NASH patients.

摘要

非酒精性脂肪性肝炎(NASH),即肝脏出现脂肪变性和纤维化,与代谢综合征相关,并会发展为肝硬化。在本研究中,利用仓鼠构建了一种源自代谢综合征的新型仓鼠NASH模型。将仓鼠分别喂食正常饮食或高脂高胆固醇(HFC)饮食12周。喂食HFC饮食的仓鼠的体重以及肝脏重量与体重之比显著高于喂食正常饮食的仓鼠。喂食HFC饮食的仓鼠血液中的甘油三酯、低密度脂蛋白胆固醇和葡萄糖水平显著升高,血压也有升高趋势,这表明喂食HFC饮食的仓鼠患上了代谢综合征。在喂食HFC饮食的仓鼠的肝脏切片中观察到了肝脂肪变性和纤维化,与NASH患者的情况一样,但在喂食正常饮食的仓鼠中未观察到。糜酶可生成血管紧张素II和转化生长因子(TGF)-β,二者均与肝脂肪变性和纤维化有关,在喂食HFC饮食的仓鼠的肝脏中观察到糜酶活性显著增强。血管紧张素II和TGF-β在喂食HFC饮食的仓鼠的肝脏中也显著增加。因此,喂食HFC饮食的仓鼠可能会患上源自代谢综合征的NASH,其临床表现与NASH患者相似。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/acc6/5955755/52b4a1109339/expanim-67-239-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/acc6/5955755/c283c4bcf6a2/expanim-67-239-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/acc6/5955755/ee35a00734ba/expanim-67-239-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/acc6/5955755/9531c9b729c6/expanim-67-239-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/acc6/5955755/20b661e84d52/expanim-67-239-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/acc6/5955755/62275a98c9fe/expanim-67-239-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/acc6/5955755/5650c494f24a/expanim-67-239-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/acc6/5955755/0c6e77616881/expanim-67-239-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/acc6/5955755/52b4a1109339/expanim-67-239-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/acc6/5955755/c283c4bcf6a2/expanim-67-239-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/acc6/5955755/ee35a00734ba/expanim-67-239-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/acc6/5955755/9531c9b729c6/expanim-67-239-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/acc6/5955755/20b661e84d52/expanim-67-239-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/acc6/5955755/62275a98c9fe/expanim-67-239-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/acc6/5955755/5650c494f24a/expanim-67-239-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/acc6/5955755/0c6e77616881/expanim-67-239-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/acc6/5955755/52b4a1109339/expanim-67-239-g008.jpg

相似文献

1
A novel hamster nonalcoholic steatohepatitis model induced by a high-fat and high-cholesterol diet.一种由高脂高胆固醇饮食诱导的新型仓鼠非酒精性脂肪性肝炎模型。
Exp Anim. 2018 May 10;67(2):239-247. doi: 10.1538/expanim.17-0126. Epub 2018 Jan 1.
2
Electronegative LDL is linked to high-fat, high-cholesterol diet-induced nonalcoholic steatohepatitis in hamsters.带负电荷的低密度脂蛋白与仓鼠高脂肪、高胆固醇饮食诱导的非酒精性脂肪性肝炎有关。
J Nutr Biochem. 2016 Apr;30:44-52. doi: 10.1016/j.jnutbio.2015.11.019. Epub 2015 Dec 28.
3
Chymase inhibitor prevents the development and progression of non-alcoholic steatohepatitis in rats fed a high-fat and high-cholesterol diet.糜蛋白酶抑制剂可预防高脂高胆固醇饮食喂养大鼠非酒精性脂肪性肝炎的发生和发展。
J Pharmacol Sci. 2017 Jul;134(3):139-146. doi: 10.1016/j.jphs.2017.04.005. Epub 2017 Jun 20.
4
Temporal Development of Dyslipidemia and Nonalcoholic Fatty Liver Disease (NAFLD) in Syrian Hamsters Fed a High-Fat, High-Fructose, High-Cholesterol Diet.高脂、高果糖、高胆固醇饮食喂养的叙利亚仓鼠血脂异常和非酒精性脂肪性肝病(NAFLD)的时间发展情况。
Nutrients. 2021 Feb 12;13(2):604. doi: 10.3390/nu13020604.
5
A diet-induced Sprague-Dawley rat model of nonalcoholic steatohepatitis-related cirrhosis.非酒精性脂肪性肝炎相关性肝硬化的饮食诱导Sprague-Dawley大鼠模型。
J Nutr Biochem. 2017 Feb;40:62-69. doi: 10.1016/j.jnutbio.2016.10.007. Epub 2016 Oct 24.
6
Dietary Supplementation with Hazelnut Oil Reduces Serum Hyperlipidemia and Ameliorates the Progression of Nonalcoholic Fatty Liver Disease in Hamsters Fed a High-Cholesterol Diet.膳食补充榛子油可降低高胆固醇饮食喂养的仓鼠的血清高血脂症并改善非酒精性脂肪性肝病的进展。
Nutrients. 2019 Sep 14;11(9):2224. doi: 10.3390/nu11092224.
7
Saturated fat and cholesterol are critical to inducing murine metabolic syndrome with robust nonalcoholic steatohepatitis.饱和脂肪和胆固醇对于引发伴有严重非酒精性脂肪性肝炎的小鼠代谢综合征至关重要。
J Nutr Biochem. 2015 Mar;26(3):285-92. doi: 10.1016/j.jnutbio.2014.11.002. Epub 2014 Dec 6.
8
Dietary fat, cholesterol, and cholic acid affect the histopathologic severity of nonalcoholic steatohepatitis in Sprague-Dawley rats.饮食中的脂肪、胆固醇和胆酸会影响 Sprague-Dawley 大鼠非酒精性脂肪性肝炎的组织病理学严重程度。
Pathol Res Pract. 2019 Nov;215(11):152599. doi: 10.1016/j.prp.2019.152599. Epub 2019 Aug 26.
9
Pathological characterization and morphometric analysis of hepatic lesions in SHRSP5/Dmcr, an experimental non-alcoholic steatohepatitis model, induced by high-fat and high-cholesterol diet.高脂高胆固醇饮食诱导的实验性非酒精性脂肪性肝炎模型SHRSP5/Dmcr中肝脏病变的病理特征及形态计量分析
Int J Exp Pathol. 2016 Feb;97(1):75-85. doi: 10.1111/iep.12169. Epub 2016 Mar 31.
10
Dietary Cholic Acid Exacerbates Liver Fibrosis in NASH Model of Sprague-Dawley Rats Fed a High-Fat and High-Cholesterol Diet.饮食胆酸加剧高脂肪高胆固醇饮食诱导的 Sprague-Dawley 大鼠非酒精性脂肪性肝炎模型的肝纤维化。
Int J Mol Sci. 2022 Aug 17;23(16):9268. doi: 10.3390/ijms23169268.

引用本文的文献

1
Downregulation of miR-122-5p Activates Glycolysis via PKM2 in Kupffer Cells of Rat and Mouse Models of Non-Alcoholic Steatohepatitis.miR-122-5p 下调通过 PKM2 激活非酒精性脂肪性肝炎大鼠和小鼠模型库普弗细胞中的糖酵解。
Int J Mol Sci. 2022 May 7;23(9):5230. doi: 10.3390/ijms23095230.
2
Chymase as a Novel Therapeutic Target in Acute Pancreatitis.糜酶在急性胰腺炎中的治疗新靶点。
Int J Mol Sci. 2021 Nov 15;22(22):12313. doi: 10.3390/ijms222212313.
3
Temporal Development of Dyslipidemia and Nonalcoholic Fatty Liver Disease (NAFLD) in Syrian Hamsters Fed a High-Fat, High-Fructose, High-Cholesterol Diet.

本文引用的文献

1
Chymase inhibitor prevents the development and progression of non-alcoholic steatohepatitis in rats fed a high-fat and high-cholesterol diet.糜蛋白酶抑制剂可预防高脂高胆固醇饮食喂养大鼠非酒精性脂肪性肝炎的发生和发展。
J Pharmacol Sci. 2017 Jul;134(3):139-146. doi: 10.1016/j.jphs.2017.04.005. Epub 2017 Jun 20.
2
Chymase inhibition improves vascular dysfunction and survival in stroke-prone spontaneously hypertensive rats.糜酶抑制可改善易卒中型自发性高血压大鼠的血管功能障碍并提高其存活率。
J Hypertens. 2014 Aug;32(8):1637-48; discussion 1649. doi: 10.1097/HJH.0000000000000231.
3
Chymase inhibitor ameliorates hepatic steatosis and fibrosis on established non-alcoholic steatohepatitis in hamsters fed a methionine- and choline-deficient diet.
高脂、高果糖、高胆固醇饮食喂养的叙利亚仓鼠血脂异常和非酒精性脂肪性肝病(NAFLD)的时间发展情况。
Nutrients. 2021 Feb 12;13(2):604. doi: 10.3390/nu13020604.
4
Efficacy and Mechanism of a Chinese Classic Prescription of Yueju in Treating Nonalcoholic Steatohepatitis and Protecting Hepatocytes from Apoptosis.一首治疗非酒精性脂肪性肝炎及保护肝细胞免受凋亡的经典中药方剂的疗效及作用机制
Evid Based Complement Alternat Med. 2020 Oct 29;2020:8888040. doi: 10.1155/2020/8888040. eCollection 2020.
5
Chymase as a Possible Therapeutic Target for Amelioration of Non-Alcoholic Steatohepatitis.糜酶作为改善非酒精性脂肪性肝炎的可能治疗靶点。
Int J Mol Sci. 2020 Oct 13;21(20):7543. doi: 10.3390/ijms21207543.
6
Comparison of a chymase inhibitor and hyaluronic acid/carboxymethylcellulose (Seprafilm) in a novel peritoneal adhesion model in rats.新型大鼠腹膜粘连模型中糜酶抑制剂与透明质酸/羧甲基纤维素(施沛特)的比较。
PLoS One. 2019 Jan 25;14(1):e0211391. doi: 10.1371/journal.pone.0211391. eCollection 2019.
糜酶抑制剂可改善蛋氨酸和胆碱缺乏饮食喂养的仓鼠非酒精性脂肪性肝炎肝脂肪变性和肝纤维化。
Hepatol Res. 2013 Sep;43(9):970-8. doi: 10.1111/hepr.12042. Epub 2013 Jan 10.
4
Multiple mechanisms for the action of chymase inhibitors.糜酶抑制剂的多种作用机制。
J Pharmacol Sci. 2012;118(3):311-6. doi: 10.1254/jphs.11r11cp. Epub 2012 Feb 14.
5
Green tea extract suppresses NFκB activation and inflammatory responses in diet-induced obese rats with nonalcoholic steatohepatitis.绿茶提取物可抑制饮食诱导肥胖伴非酒精性脂肪性肝炎大鼠 NFκB 的激活和炎症反应。
J Nutr. 2012 Jan;142(1):57-63. doi: 10.3945/jn.111.148544. Epub 2011 Dec 7.
6
Development of novel rat model for high-fat and high-cholesterol diet-induced steatohepatitis and severe fibrosis progression in SHRSP5/Dmcr.建立新型高脂肪高胆固醇饮食诱导的 SHRSP5/Dmcr 大鼠肝脂肪性肝炎和严重纤维化进展模型。
Environ Health Prev Med. 2012 May;17(3):173-82. doi: 10.1007/s12199-011-0235-9. Epub 2011 Aug 19.
7
The role of thiazolidinediones in non-alcoholic steatohepatitis - a systematic review and meta analysis.噻唑烷二酮类药物在非酒精性脂肪性肝炎中的作用——系统评价和荟萃分析。
J Hepatol. 2011 Dec;55(6):1383-90. doi: 10.1016/j.jhep.2011.03.016. Epub 2011 Apr 14.
8
Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis.非酒精性脂肪性肝病中炎症的演变:多重重击假说。
Hepatology. 2010 Nov;52(5):1836-46. doi: 10.1002/hep.24001.
9
The fatty acid composition of plasma cholesteryl esters and estimated desaturase activities in patients with nonalcoholic fatty liver disease and the effect of long-term ezetimibe therapy on these levels.非酒精性脂肪肝患者血浆胆固醇酯的脂肪酸组成和估计的去饱和酶活性,以及长期依折麦布治疗对这些水平的影响。
Clin Chim Acta. 2010 Nov 11;411(21-22):1735-40. doi: 10.1016/j.cca.2010.07.012. Epub 2010 Jul 21.
10
Chymase inhibitor prevents the nonalcoholic steatohepatitis in hamsters fed a methionine- and choline-deficient diet.糜酶抑制剂可预防蛋氨酸和胆碱缺乏饮食喂养的仓鼠的非酒精性脂肪性肝炎。
Hepatol Res. 2010 May;40(5):514-23. doi: 10.1111/j.1872-034X.2010.00627.x. Epub 2010 Mar 30.